Mardi Dier - Sep 16, 2022 Form 4 Insider Report for Ultragenyx Pharmaceutical Inc. (RARE)

Role
CFO & Executive Vice President
Signature
/s/ Karah Parschauer, attorney-in-fact
Stock symbol
RARE
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
4
Date filed
9/19/2022, 09:39 PM
Previous filing
Jun 22, 2022
Next filing
Oct 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RARE Common Stock Award $0 +20K +38.6% $0.00 71.8K Sep 16, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
F2 Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.